| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21AG065657 | Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimer's Disease | 000 | 1 | NIH | 12/4/2023 | $0 |
| | 2024 | 2019 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | RF1AG060769 | Targeting REV-ERB to treat Alzheimer's disease | 001 | 6 | NIH | 3/15/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = -$798,445 ) |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01DA057790 | Targeting the allosteric sodium site with novel probes for delta opioid receptor | 001 | 1 | NIH | 8/28/2023 | -$695,152 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01DA057790 | Targeting the allosteric sodium site with novel probes for delta opioid receptor | 000 | 1 | NIH | 6/26/2023 | $695,152 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21DK132605 | Investigation and Targeting of Alternate Binding Site in ERR? | 000 | 2 | NIH | 3/16/2023 | $193,888 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 000 | 5 | NIH | 8/8/2023 | $709,352 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 001 | 5 | NIH | 8/9/2023 | $109,174 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01NS123070 | Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity | 000 | 2 | NIH | 3/17/2023 | $427,807 |
| | 2023 | 2023 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01NS126204 | Developing Chemical Probes for Inflammatory Pain | 001 | 2 | NIH | 7/21/2023 | $625,005 |
| | 2023 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01NS126204 | Developing Chemical Probes for Inflammatory Pain | 000 | 1 | NIH | 7/20/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R15AG077421 | Iron Metabolism in Ts65Dn mice, a Model of Down syndrome | 000 | 1 | NIH | 1/18/2023 | $0 |
| | 2023 | 2021 | University of Health Sciences and Pharmacy in St. Louis | 1 Pharmacy Pl | Saint Louis | MO | 63110-1009 | SAINT LOUIS CITY | USA | E1327356 | HPSL - Pharmacy | 002 | 4 | HRSA | 11/28/2022 | -$800,365 |
| | 2023 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | F32AG062035 | Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease | 000 | 3 | NIH | 5/15/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33DA045884 | Pharmacological Probes based on mitragynine pseudoindoxyl | 000 | 4 | NIH | 8/30/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R34NS126036 | Synthesis of peripherally active CB1 agonists as analgesics | 000 | 1 | NIH | 8/23/2023 | -$555,968 |
| | 2023 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21HD099573 | Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome | 005 | 2 | NIH | 9/14/2023 | $112,500 |
| | 2023 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21HD099573 | Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome | 005 | 2 | NIH | 9/14/2023 | $214,857 |
| | 2023 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21HD099573 | Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome | 001 | 2 | NIH | 5/25/2023 | $153,010 |
| | 2023 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21HD099573 | Heart and vascular responses across the lifespan in Ts65Dn mice, a model of Down syndrome | 002 | 2 | NIH | 9/11/2023 | $0 |
| | 2023 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21DA048650 | Rapid and sensitive in vivo detection of opioid peptides | 000 | 2 | NIH | 4/13/2023 | $0 |
| | 2023 | 2019 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | RF1AG060769 | Targeting REV-ERB to treat Alzheimer's disease | 000 | 6 | NIH | 1/25/2023 | -$1,987,705 |
|
| Issue Date FY: 2022 ( Subtotal = $2,522,844 ) |
| | 2022 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01NS123070 | Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity | 000 | 1 | NIH | 3/31/2022 | $441,584 |
| | 2022 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21DK132605 | Investigation and Targeting of Alternate Binding Site in ERR? | 000 | 1 | NIH | 3/25/2022 | $193,888 |
| | 2022 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01NS126204 | Developing Chemical Probes for Inflammatory Pain | 000 | 1 | NIH | 7/23/2022 | $636,751 |
| | 2022 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R15AG077421 | Iron Metabolism in Ts65Dn mice, a Model of Down syndrome | 000 | 1 | NIH | 8/29/2022 | $465,330 |
| | 2022 | 2022 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 001 | 4 | NIH | 8/23/2022 | $804,143 |
| | 2022 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | F32AG062035 | Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease | 001 | 3 | NIH | 6/29/2022 | -$18,852 |
| | 2022 | 2021 | University of Health Sciences and Pharmacy in St. Louis | 1 Pharmacy Place | Saint Louis | MO | 63110-1009 | SAINT LOUIS CITY | USA | E13HP27356 | HPSL - Pharmacy | 001 | 4 | HRSA | 12/14/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 000 | 3 | NIH | 5/9/2022 | $216,870 |
| | 2022 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R61HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 000 | 2 | NIH | 5/9/2022 | -$216,870 |
| | 2022 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | R21AG065657 | Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimer's Disease | 000 | 1 | NIH | 1/28/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | F32AG062035 | Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease | 000 | 3 | NIH | 6/28/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01MH092769 | Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders | 000 | 11 | NIH | 8/29/2022 | $0 |
| | 2022 | 2019 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R00DA038725 | DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORS | 000 | 5 | NIH | 5/10/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $3,610,161 ) |
| | 2021 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | R33DA045884 | Pharmacological Probes based on mitragynine pseudoindoxyl | 000 | 4 | NIH | 8/20/2021 | $395,106 |
| | 2021 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | F32AG062035 | Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease | 001 | 3 | NIH | 8/25/2021 | $70,458 |
| | 2021 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | R33HD099748 | SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices | 000 | 3 | NIH | 8/24/2021 | $754,905 |
| | 2021 | 2021 | University of Health Sciences and Pharmacy in St. Louis | 4588 Parkview Pl | SAINT LOUIS | MO | 63110-1088 | SAINT LOUIS CITY | USA | E1327356 | HPSL - Pharmacy | 000 | 4 | HRSA | 8/19/2021 | $800,365 |
| | 2021 | 2021 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | R34NS126036 | Synthesis of peripherally active CB1 agonists as analgesics | 000 | 1 | NIH | 9/24/2021 | $1,589,327 |
| | 2021 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R33DA045884 | Pharmacological Probes based on mitragynine pseudoindoxyl | 001 | 3 | NIH | 9/27/2021 | $10,043 |
| | 2021 | 2020 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1029 | SAINT LOUIS CITY | USA | F32AG062035 | Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease | 000 | 3 | NIH | 8/25/2021 | $0 |
| | 2021 | 2019 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R21DA045884 | Pharmacological Probes based on mitragynine pseudoindoxyl | 000 | 2 | NIH | 9/27/2021 | -$10,043 |
| | 2021 | 2019 | ST. LOUIS COLLEGE OF PHARMACY | 4588 PARKVIEW PL | SAINT LOUIS | MO | 63110-1088 | SAINT LOUIS CITY | USA | RF1AG060769 | Targeting REV-ERB to treat Alzheimer's disease | 000 | 6 | NIH | 10/15/2020 | $0 |
| | 2021 | 2018 | University of Health Sciences and Pharmacy in St. Louis | 4588 Parkview Pl | SAINT LOUIS | MO | 63110-1088 | SAINT LOUIS CITY | USA | E1327356 | HPSL - Pharmacy | 002 | 3 | HRSA | 4/1/2021 | $0 |
| | 2021 | 2018 | UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS | 1 PHARMACY PL | SAINT LOUIS | MO | 63110-1009 | SAINT LOUIS CITY | USA | R01AR069280 | ERRgamma Agonists to Treat Muscular Dystrophy | 000 | 3 | NIH | 3/11/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,375,228 ) (Continued on the next page) |
|
